Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Office systolic blood pressure that remains ≥160 mmHg (≥150 mmHg for patient with type 2 diabetes) despite the stable use of ≥3 antihypertensive medications concurrently at maximally tolerated doses, of which one is a diuretic, for a minimum of 14 days prior to enrollment~* Age ≥18 and ≤80 years old~* Able and willing to provide written informed consent to participate in the study~* Able and willing to comply with the required follow-up schedule~Exclusion Criteria:~* Prior renal artery intervention (balloon angioplasty or stenting)~* Evidence of renal artery atherosclerosis (defined as a stenotic severity of \>30%) in either renal artery~* Multiple main renal arteries in either kidney~* Main renal arteries \<4 mm in diameter or \<20 mm in length~* eGFR of \<45 mL/min per 1.73 m2 using the MDRD formula~* Type 1 diabetes~* Renovascular hypertension or hypertension secondary to other renal disorders (glomerulonephritis, polycystic kidney disease, end-stage renal failure)~* Others

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- renal artery ablation (Type: EXPERIMENTAL): Catheter-based RF ablation in renal artery

Based on this trial design, predict the completion outcome and termination type (if applicable).